Beone Medicines I competitive analysis

Explore Beone Medicines I's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 25, 2026Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses Thereof5

Latest PTAB cases involving Beone Medicines I

Discover the latest PTAB cases involving Beone Medicines I, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Beone Medicines I with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BEONE MEDICINES I - 5 - -
DEVA HOLDING4 - - -
EGIS10 - - -
HAMPTON KNOWLES39 - - -